Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden
Cancers · 28.10.2025 · 17 (21) · 3459
DOI: 10.3390/cancers17213459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 28.10.2025. Verfasst von Minji K Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, CCR NIH HHS, US National Cancer Institute.
Abstract (Originalsprache)
Background
The PRO-CTCAE provides patient-reported data on symptomatic AEs. A summary metric—the ACS—reflecting total AE burden can be calculated by averaging AE-level composite scores at a given timepoint for each participant. This study investigated the psychometric properties and interpretability of this PRO-CTCAE ACS in patients with breast, lung, or head/neck cancers.
Methods
We conducted a secondary analysis of a PRO-CTCAE validation dataset comprising 940 adults undergoing chemotherapy or radiation therapy (clinicaltrials.gov: NCT02158637). We focused on empirically recommended symptom terms for three cancer sites. Analyses included Spearman’s correlations, coefficient alpha, and eigenvalues from the correlation matrices, confirmatory factor analysis (CFA), and principal component analysis (PCA). Latent profile analysis (LPA) was used to assess ACS interpretability in the lung cohort.
Results
Mean composite score inter-correlations were moderate (0.30–0.35), and coefficient alphas were high (0.81–0.91). Eigenvalue ratios and CFA supported retention of a single factor/component, with suitable model fit indices. ACS correlated highly with factor scores and the first principal component from the PCA. Reduced sets of terms produced reliable scores that closely approximated the full set scores and aligned with external criteria. LPA in the lung subgroup identified four latent classes; ACS differentiated high vs. low symptom burden groups but did not distinguish the two groups expressing distinct symptom profiles.
Conclusion
The ACS demonstrated structural validity through adequately fitting linear factor models and effectively summarized symptomatic AE burden. However, similar ACS values may mask clinically distinct symptomatic AE profiles, underscoring the value of both summary metrics and profile-based approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
- Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD 20850, USA.
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
- Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
- Center for Cancer Research, National Cancer Institute, Rockville, MD 20850, USA.
ORCID-Profile: Minji K Lee, Sandra A Mitchell, Allison M Deal, Lauren Rogak, Antonia V Bennett, Gina L Mazza, Amylou C Dueck
Förderung
- NCI NIH HHS
- CCR NIH HHS
- US National Cancer Institute
Zitieren
APA
Lee, M. K., Mitchell, S. A., Basch, E., Deal, A. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L., Mendoza, T. R., Bennett, A. V., Noble, B. N., Mazza, G. L., & Dueck, A. C. (2025). Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden. Cancers, 17(21), 3459. https://doi.org/10.3390/cancers17213459
Vancouver
Lee MK, Mitchell SA, Basch E, Deal AM, Langlais BT, Thanarajasingam G, et al. Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden. Cancers. 2025;17(21):3459. doi:10.3390/cancers17213459
BibTeX
@article{Lee2025,
author = {Lee, Minji K and Mitchell, Sandra A and Basch, Ethan and Deal, Allison M and Langlais, Blake T and Thanarajasingam, Gita and Ginos, Brenda F and Rogak, Lauren and Mendoza, Tito R and Bennett, Antonia V and Noble, Brie N and Mazza, Gina L and Dueck, Amylou C},
title = {Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden},
journal = {Cancers},
year = {2025},
volume = {17},
number = {21},
pages = {3459},
doi = {10.3390/cancers17213459}
}
EUVIMED